Designed De Novo α-Sheet Peptides Destabilize Bacterial Biofilms and Increase the Susceptibility of E. coli and S. aureus to Antibiotics

Tatum Prosswimmer,Sarah E. Nick,James D. Bryers,Valerie Daggett
DOI: https://doi.org/10.3390/ijms25137024
IF: 5.6
2024-06-27
International Journal of Molecular Sciences
Abstract:Biofilm-associated microbes are 10–1000 times less susceptible to antibiotics. An emerging treatment strategy is to target the structural components of biofilm to weaken the extracellular matrix without introducing selective pressure. Biofilm-associated bacteria, including Escherichia coli and Staphylococcus aureus, generate amyloid fibrils to reinforce their extracellular matrix. Previously, de novo synthetic α-sheet peptides designed in silico were shown to inhibit amyloid formation in multiple bacterial species, leading to the destabilization of their biofilms. Here, we investigated the impact of inhibiting amyloid formation on antibiotic susceptibility. We hypothesized that combined administration of antibiotics and α-sheet peptides would destabilize biofilm formation and increase antibiotic susceptibility. Two α-sheet peptides, AP90 and AP401, with the same sequence but inverse chirality at every amino acid were tested: AP90 is L-amino acid dominant while AP401 is D-amino acid dominant. For E. coli, both peptides increased antibiotic susceptibility and decreased the biofilm colony forming units when administered with five different antibiotics, and AP401 caused a greater increase in all cases. For S. aureus, increased biofilm antibiotic susceptibility was also observed for both peptides, but AP90 outperformed AP401. A comparison of the peptide effects demonstrates how chirality influences biofilm targeting of gram-negative E. coli and gram-positive S. aureus. The observed increase in antibiotic susceptibility highlights the role amyloid fibrils play in the reduced susceptibility of bacterial biofilms to specific antibiotics. Thus, the co-administration of α-sheet peptides and existing antibiotics represents a promising strategy for the treatment of biofilm infections.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
This paper primarily explores how designed synthetic α-sheet peptides disrupt bacterial biofilms and increase the sensitivity of *Escherichia coli* (abbreviated as *E. coli*) and *Staphylococcus aureus* (abbreviated as *S. aureus*) to antibiotics. ### Research Background - Microorganisms associated with biofilms exhibit a 10 to 1000-fold reduction in antibiotic sensitivity. - Various bacteria such as *E. coli* and *S. aureus* produce amyloid fibers within biofilms to reinforce their extracellular matrix. - Previous studies have shown that novel α-sheet peptides, designed through computer-aided methods, can inhibit amyloid fiber formation in multiple bacteria, leading to biofilm disruption. ### Research Objectives - To investigate the impact of inhibiting amyloid fiber formation on enhancing antibiotic sensitivity. - To hypothesize that the combined use of antibiotics and α-sheet peptides can disrupt biofilm structure and increase antibiotic sensitivity. ### Key Findings - Two α-sheet peptides (AP90 and AP401) were tested, which have the same sequence but opposite chirality. - For *E. coli*, both peptides increased antibiotic sensitivity and reduced colony-forming units (CFUs) in biofilm formation. Particularly, when combined with five different antibiotics, AP401 was more effective in all cases. - For *S. aureus*, an increase in biofilm antibiotic sensitivity was observed, but AP90 was more effective than AP401 for both peptides. - Chirality affects the targeting of biofilms in *E. coli* (Gram-negative) and *S. aureus* (Gram-positive) differently. ### Conclusion - Inhibiting amyloid fiber formation can significantly enhance the sensitivity of *E. coli* and *S. aureus* to specific antibiotics. - Therefore, the combined use of α-sheet peptides with existing antibiotics represents a promising strategy for treating biofilm infections. In summary, this paper demonstrates how α-sheet peptides can effectively enhance the therapeutic efficacy of antibiotics against biofilm-associated bacteria, providing important theoretical and technical support for developing new antibacterial strategies.